Regulation of Hippo Signaling and Triple Negative Breast Cancer Progression by an Ubiquitin Ligase RNF187
Zhonghao Wang,Qiong Kong,Peng Su,Miao Duan,Min Xue,Xin Li,Jianing Tang,Zhitao Gao,Beibei Wang,Zhongbo Li,Yun Liu,Xiao Yang,Ruilin Cao,Tingting Song,Ke Wang,Yuqing Cai,Danfeng Wu,Jinglei Li,Gaosong Wu,Asha M. Guled,Jian Zhu,Cheng Yan,Ting Zhuang
DOI: https://doi.org/10.1038/s41389-020-0220-5
2020-01-01
Oncogenesis
Abstract:Breast cancer is the most common malignancy for women worldwide, while Triple Negative Breast Cancer (TNBC) accounts for 20% in all patients. Compared with estrogen receptor positive breast cancer, which could be effectively controlled via endocrine therapy, TNBC is more aggressive and worse in prognosis. It is therefore urgent and necessary to develop a novel therapeutic strategy for TNBC treatment. Recent studies identified Hippo signaling is highly activated in TNBC, which could be a driving pathway for TNBC progression. In our study, we determine RNF187 as a negative regulator for Hippo signaling activation. RNF187 depletion significantly decreases cell migration and invasion capacity in TNBC. These effects could be rescued by further YAP depletion. Depletion of RNF187 increases the YAP protein level and Hippo signaling target genes, such as CTGF and CYR61 in TNBC. Immuno-precipitation assay shows that RNF187 associates with YAP, promoting its degradation possibly via inducing YAP K48-dependent poly-ubiquitination. Interestingly, Our clinical data reveals that RNF187 reversely correlates with YAP protein level and Hippo target genes. RNF187 tends to correlate with good prognosis in TNBC patients. Our study provides evidence to establish a proteolytic mechanism in regulation Hippo signaling activation in TNBC.